Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
Details for 2015738359
Up to date per 14.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2015738359
Title / Product Name
ONKOLYTISCHES VIRUS ZUR EXPRESSION VON IMMUNOLOGISCHEN PRÜFPUNKTMODULATOREN
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2015738359
EP Publication Number
3169341
E-Number
1139303
Language
EN
PCT Number
EP15066263
Publication Date
24.05.2017 A
05.06.2019 B1
Registration Date
05.06.2019
AT Publication Date
15.06.2019
Application Date
16.07.2015
Registration Number
-
Priorities
16.07.2014
EP
14306153
IPC
A61K 35/768 20150101AFI20160125BHEP
Maximum Duration of Protection
16.07.2035
Owner
Transgene SA
Parc d'Innovation Boulevard Gonthier d`Andernach
67400 Illkirch Graffenstaden
FR
Representative
Representative
Kliment & Henhapel Patentanwälte OG
Gonzagagasse 15
1010 Wien
AT
Inventor
SILVESTRE, Nathalie
6 rue des Iris
F-67120 Ergersheim
FR
GEIST, Michel
18 rue Edouard Manet
F-67170 Brumath
FR
RITTNER, Karola
51 rue des Pluviers
F-67100 Strasbourg
FR
MARCHAND, Jean-Baptiste
1A rue des Hauts Pâturages
F-67210 Obernai
FR
THIOUDELLET, Christine
4 boulevard de la Victoire
F-67000 Strasbourg
FR
Information about Fees
Click here to load the fees
see.ip - Details for ONKOLYTISCHES VIRUS ZUR EXPRESSION VON IMMUNOLOGISCHEN PRÜFPUNKTMODULATOREN